Author
Rockefeller UniversityORCID 0000-0002-8942-1551Unclaimed ORCID profile · follow to get notified of new preprints
5 papers
Recent·Most cited
Clayton K. Mickelson, Mark Salnikov, Frances K. Shepherd…·Ryan A. Langlois
The paper uses fibroblasts from 86 mammalian species to study virus-host susceptibility and innate immune responses across diverse mammals.
Jordan Anderson-Daniels, Meghan V. Diefenbacher, Boyd L. Yount…·Timothy Patrick Sheahan
This study shows that SARS-CoV-2 with impaired nsp14-exonuclease activity has reduced replication, fitness, and pathogenesis, but remains viable in some conditions.
Mariana Nogueira Batista, Juliano Bordignon, Ana Luiza Pamplona Mosimann…·Charles M. Rice
This study develops an immunocompetent mouse model of virus-induced liver fibrosis and hepatocellular carcinoma using Norway rat hepacivirus.
Jérémie Le Pen, Gabrielle Paniccia, Volker Kinast…·Charles M. Rice
The paper identifies PLSCR1 as a host factor restricting SARS-CoV-2 entry, which recent variants have evolved to bypass, through a CRISPR screen and integration of genetic studies.
Timothy E. Gressett, Sarah R. Leist, Saifudeen Ismael…·Gregory Jaye Bix
This study shows that MA10 SARS-CoV-2 infection in mice leads to neuropathological changes in the hippocampus, mirroring the prevalence of Long COVID in humans.